Dennis Podlesak
CIK 1314595 · last filed 2026-02-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.38M
Companies
4
Total Filings
34
Lifetime Open-Market Net
-$2.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNDX | Director | 239,763 | $18.25 | $4.38M | -$2.58M | 16 | 2026-02-06 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 3 | 2016-01-14 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 336,394 | — | — | $0 | 8 | 2014-02-14 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Director | — | — | — | $0 | 2 | 2014-01-03 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-05-20 | — | Mixed | — | $0 | |
| 2008-02-25 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +56,911 | $0 | EDGAR |
| 2007-08-13 | — | Grant (A) | — | $0 | |
| 2007-03-05 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +44,248 | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.